Index Investing News
Friday, May 30, 2025
No Result
View All Result
  • Login
  • Home
  • World
  • Investing
  • Financial
  • Economy
  • Markets
  • Stocks
  • Crypto
  • Property
  • Sport
  • Entertainment
  • Opinion
  • Home
  • World
  • Investing
  • Financial
  • Economy
  • Markets
  • Stocks
  • Crypto
  • Property
  • Sport
  • Entertainment
  • Opinion
No Result
View All Result
Index Investing News
No Result
View All Result

Dividend Aristocrats In Focus: Kenvue

by Index Investing News
November 21, 2023
in Investing
Reading Time: 5 mins read
A A
0
Home Investing
Share on FacebookShare on Twitter


Published on November 21st, 2023 by Bob Ciura

The Dividend Aristocrats consist of 68 companies in the S&P 500 Index that have raised their dividends for at least 25 years in a row. Many of the companies have turned into huge multinational corporations over the decades.

You can see the full list of all 68 Dividend Aristocrats here.

We created a full list of all Dividend Aristocrats, along with important financial metrics like price-to-earnings ratios and dividend yields. You can download your copy of the Dividend Aristocrats list by clicking on the link below:

 

Kenvue Inc. (KVUE) is the most recent addition to the Dividend Aristocrats list, having recently been spun off from former parent company Johnson & Johnson (JNJ).

This article will analyze Kenvue’s business model, future growth catalysts, and expected returns.

Business Overview

Kenvue operates in the healthcare sector as a consumer products manufacturer. In May 2023, Kenvue was spun off from Johnson & Johnson. Now, Kenvue operates three segments: Self Care, Skin Health and Beauty, and Essential Health.

Self Care’s product portfolio includes cough, cold, allergy, smoking cessation, and pain care products among others. Skin Health and Beauty holds products such as face, body, hair, and sun care. Essential Health contains products for women’s health, wound care, oral care, and baby care.

Well-known brands in Kenvue’s product line up include Tylenol, Listerine, Band-Aid, Neutrogena, Nicorette, and Zyrtec. These businesses contributed approximately 17% of Johnson & Johnson’s annual revenue.

On October 26th, 2023, Kenvue reported third quarter earnings results for the period ending October 1st, 2023. Revenue grew 3.4% to $3.92 billion, which was $10 million above estimates.

Source: Investor Presentation

Adjusted earnings-per-share of $0.31 was in-line with expectations. Organic sales grew 3.6% as pricing and mix were partially offset by a 3.5% decline in volume. Cold and cough were again strong while skin, health, and beauty also showed gains. Gross profit margin improved 140 basis points to 57.5%.

Kenvue also provided an updated outlook for 2023. The company now expects revenue growth to be in a range of 4.0% to 4.5% and organic growth of 5.5% to 6.0%, down from 4.5% to 5.5% and 5.5% to 6.5%, respectively. Kenvue projects adjusted earnings-per-share to be in a range of $1.26 to $1.28 for the year.

Growth Prospects

Johnson & Johnson produced annual earnings growth of 7% for the 2013 to 2022 period as the company’s diversification allowed it to be one of the more stable companies in the market place. Kenvue consists of just the consumer products businesses, which were often produced the lowest levels of growth. Therefore, we expect that Kenvue will grow earnings-per-share by 3% annually through 2028.

Johnson & Johnson’s dividend growth streak of 61 consecutive years is one of the longest in the market place. The company is both a Dividend King and a Dividend Aristocrat. We believe that penchant for dividend growth is in Kenvue’s business DNA.

Competitive Advantages & Recession Performance

Kenvue’s former parent company Johnson & Johnson has proven to be one of the most successful companies at navigating recessions. Though Kenvue no longer benefits from its parent company’s diversification, we believe that it would prove equally effective at handling economic downturns.

Since Kenvue was a subsidiary of Johnson & Johnson during the Great Recession of 2008-2009, there is no data on its earnings-per-share performance during that time. However, investors can reasonably infer that Kenvue would display a similar degree of resilience during recessions as its former parent company.

The company’s products, such as Band-Aid and Tylenol, are needed regardless of the state of the economy as they deal directly with consumers’ health and well-being. As trusted products, they would like continue to perform well even under adverse conditions.

Overall, Kenvue should continue to raise its dividend for many more years thanks to its low payout ratio, its decent resilience to recessions, and its healthy balance sheet.

Valuation & Expected Returns

We expect Kenvue to generate adjusted earnings-per-share of $1.27 for 2023. Therefore, shares of Kenvue currently trade for a price-to-earnings ratio of 15.6. For context, Johnson & Johnson shares have an average price-to-earnings ratio of close to 19 since 2013.

Countering the fact that Kenvue holds some of the industry leading brands with that its products were the lower margin businesses within the parent company, we have a target price-to-earnings ratio of 14 for the stock. This implies a headwind from multiple contraction.

Therefore, valuation could reduce annual returns by 2.1% if the stock were to reach our target multiple by 2028. Positive returns will be generated by EPS growth (estimated at 3% per year) and dividends.

On July 20th, 2023, Kenvue announced its first-ever quarterly dividend of $0.20 per share to be distributed on September 7th, 2023. The annualized payout of $0.80 per share represents a current yield of 4.0%.

Putting it all together, total returns are expected to reach 4.9% per year through 2028. This is a solid expected rate of return that makes the stock a hold, but not a buy at this time.

Final Thoughts

Kenvue is a new addition to the Dividend Aristocrats list. After decades as part of Johnson & Johnson, Kenvue became an independent entity early in the second quarter. The company has produced decent results so far as an independent company.

While we find the legacy business to be recession-resistant and the high dividend yield to be attractive for income investors, the total return profile is not high enough for a buy recommendation. We rate KVUE stock to be a hold.

Additionally, the following Sure Dividend databases contain the most reliable dividend growers in our investment universe:

  • The Dividend Champions: Dividend stocks with 25+ years of dividend increases, including those that may not qualify as Dividend Aristocrats.
  • The Best DRIP Stocks: The top 15 Dividend Aristocrats with no-fee dividend reinvestment plans.

If you’re looking for stocks with unique dividend characteristics, consider the following Sure Dividend databases:

The major domestic stock market indices are another solid resource for finding investment ideas. Sure Dividend compiles the following stock market databases and updates them monthly:

Thanks for reading this article. Please send any feedback, corrections, or questions to [email protected].





Source link

Tags: AristocratsDividendfocusKenvue
ShareTweetShareShare
Previous Post

Why “Subject To” is One of Your Best Creative Finance Options In This Market

Next Post

England flanker Tom Curry ruled out of Six Nations with hip injury

Related Posts

Capital Formation in Africa: A Case for Personal Markets

Capital Formation in Africa: A Case for Personal Markets

by Index Investing News
May 29, 2025
0

Government Abstract This CFA Institute report examines the challenges surrounding capital formation in sub-Saharan Africa and explores the potential position...

The High 7 Canadian Oil Shares, Ranked In Order

The High 7 Canadian Oil Shares, Ranked In Order

by Index Investing News
May 28, 2025
0

Revealed on Could twenty eighth, 2025 by Bob Ciura Canadian oil shares have confirmed over the previous decade that they'll...

Tariffs, Inflation, and Returns: How Investments Reply to Provide Shocks

Tariffs, Inflation, and Returns: How Investments Reply to Provide Shocks

by Index Investing News
May 28, 2025
0

Tariffs have reclaimed the financial highlight. However with their timing and magnitude unsure, traders are on edge. An interesting historical...

Ladies in Alts: Main with Inspiration, Instinct, and Impression

Ladies in Alts: Main with Inspiration, Instinct, and Impression

by Index Investing News
May 27, 2025
0

Ladies investing in alternate options aren’t simply constructing wealth — they’re reshaping the longer term. With capital comes energy, and...

5 Purple Flag Dividend Champions Most Doubtless To Minimize Their Dividends

5 Purple Flag Dividend Champions Most Doubtless To Minimize Their Dividends

by Index Investing News
May 27, 2025
0

Printed on Might twenty seventh, 2025 by Bob CiuraSpreadsheet knowledge up to date each day Traders are probably acquainted with...

Next Post
England flanker Tom Curry ruled out of Six Nations with hip injury

England flanker Tom Curry ruled out of Six Nations with hip injury

JPMorgan Uses Avalanche Crypto to “Tokenize” Finance

JPMorgan Uses Avalanche Crypto to “Tokenize” Finance

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

RECOMMENDED

Kim Kardashian Urges An Unexpected ‘Call To Action’ After Hamas Terrorist Attacks

Kim Kardashian Urges An Unexpected ‘Call To Action’ After Hamas Terrorist Attacks

October 12, 2023
U.S. IPO market started to recover in 2023, but global market fell further (NYSEARCA:IPO)

U.S. IPO market started to recover in 2023, but global market fell further (NYSEARCA:IPO)

January 1, 2024
Taylor Swift Wore a  Corset Top in New York City: How to Shop the Singer’s Recent Street Style Looks

Taylor Swift Wore a $58 Corset Top in New York City: How to Shop the Singer’s Recent Street Style Looks

July 4, 2023
Titan Q3 business update: Firm sees 22% growth, led by jewellery segment

Titan Q3 business update: Firm sees 22% growth, led by jewellery segment

January 6, 2024
Rating the ten finest gamers in NL East

Rating the ten finest gamers in NL East

January 11, 2025
SEC Sues Binance, Coinbase Then BlackRock Files For Bitcoin Spot ETF; Is This An Inside Job?

SEC Sues Binance, Coinbase Then BlackRock Files For Bitcoin Spot ETF; Is This An Inside Job?

June 21, 2023
DWTS’ Gleb Savchenko Reveals Why He Ended Issues with Brooks Nader Over Textual content

DWTS’ Gleb Savchenko Reveals Why He Ended Issues with Brooks Nader Over Textual content

November 13, 2024
Nation is gasping for skilled workers

Nation is gasping for skilled workers

May 3, 2023
Index Investing News

Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.

  • 1717575246.7
  • Browse the latest news about investing and more
  • Contact us
  • Cookie Privacy Policy
  • Disclaimer
  • DMCA
  • Privacy Policy
  • Terms and Conditions
  • xtw18387b488

Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.

No Result
View All Result
  • Home
  • World
  • Investing
  • Financial
  • Economy
  • Markets
  • Stocks
  • Crypto
  • Property
  • Sport
  • Entertainment
  • Opinion

Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In